Turn in Illegal Knives for a Free Year of Netflix, German Police Suggest
People who voluntarily hand in banned and dangerous knives should be rewarded with a year-long Netflix subscription, the head of one of the largest German police unions has said.
The most popular pocket knife costs €17 while an annual Netflix subscription amounts to €170, making the exchange worthwhile for anyone willing to dispose of their knives. “For this measure to be effective, the federal government must create serious incentives for sellers,” Jochen Kopelke, head of the Gewerkschaft der Polizei (GdP), added.
Knife crime has been soaring in Germany: according to police statistics, close to 13,844 knife-related attacks were committed last year, a significant increase compared to the 10,131 cases recorded a year earlier. The Charité hospital in Berlin said this week that the number of patients treated for stab wounds this year has already reached 50 to 55—a number they usually tend to in a whole year. “This is a threatening development for society,” Ulrich Stöckle, managing director of the hospital’s Centre for Musculoskeletal Surgery, said.
Most of the perpetrators of violence in Berlin “are young, male and have a non-German background. This also applies to knife violence,” Barbara Slowik, the police commissioner of Berlin recently said in an interview.
Knife crime has been especially rife among the migrant communities in Germany, with Syrian and Afghan perpetrators making the headlines in recent months. One of the most shocking attacks was committed by an Afghan failed asylum seeker in May in Mannheim: the 25-year-old man, who had been living in the country illegally for nine years, murdered a policeman.
Most recently, a Syrian migrant seriously injured a four-year-old girl in a supermarket in the southern German city of Wangen im Allgäu, and a 17-year-old Syrian was arrested for stabbing a family of five in Stuttgart. The latter case is particularly disturbing, as the attacker had reportedly committed 34 criminal acts in 31 months—but the police kept letting him go.
Support for resuming deportations to both Syria and Afghanistan has increased, but the government is unwilling to deport dangerous criminals because Germany has declared both countries unsafe.
Readers of the German daily Bild, the country’s highest-circulation newspaper, vented their anger at the government for doing nothing. “Deport everyone who is dangerous. Enough is enough,” wrote one of them. “These types of criminals are ridiculing our country,” wrote another. A third reader compared the situation to recent violent protests in Britain, saying: “Politicians are horrified, but no one is taking action. We can already see in England where this type of behaviour leads to.”
In response to the high-profile acts of political violence, politicians from both the Left and Right have called for stricter controls on the possession of knives in public. Jochen Kopelke welcomed proposals for a ban on carrying knives, but he emphasised that increased police controls would be required, as well as additional personnel and improved equipment for the police.
Germany already has strict regulations on carrying knives in public, with blades over 12 cm banned except in certain circumstances.
Pharma, WHO Team up to Create Permanent ‘Pandemic’ Market for Mandated, Experimental Vaccines
Big Pharma and its key investors are rolling out a new strategy — “the full takeover of the public sector, specifically the World Health Organization (WHO), and the regulatory system that now holds the entire market hostage” — according to a new investigative report by Unlimited Hangout’s Max Jones.
What’s behind the new strategy? The pharmaceutical industry is facing a “patent cliff” by 2030, as many of its blockbuster drugs are set to lose their patent protection, placing $180 billion in sales at risk and threatening to topple the industry.
According to Jones, for years, when patents expired on profitable drugs, pharmaceutical giants deployed a “mergers and acquisitions” strategy, buying up smaller drug companies to add to their product portfolios.
As a result, the industry is now dominated by a handful of companies, conventional chemical drugs exist for most health issues, and the regulatory process for new ones has become onerous.
Big Pharma has now pivoted to acquiring biotech and biologic companies, whose products are “more complex, unpredictable and difficult and expensive to make,” than chemical-based medicine, Jones wrote.
Conventional drugs are chemically synthesized and have a known structure according to the U.S. Food and Drug Administration (FDA). Biologics come from living humans, animal or microorganism cells, and are technologically altered to target particular proteins or cells in the immune system. The FDA calls biologics “complex mixtures that are not easily identified or characterized.”
As a drug class, biologics offer an appealing solution to the patent cliff problem, because they can’t be easily replicated like generic versions of conventional drugs.
Instead, producers make “biosimilars,” which unlike genetics can’t simply be interchanged with the original drug during a course of treatment without serious safety risks, according to Jones. And while generics are cheap, biosimilars are still expensive to produce. There also are regulatory hurdles to getting biosimilars to market.
However, Jones wrote, the serious safety issues associated with biologics — the high risk of serious adverse events associated with the COVID-19 vaccine, for example — make it difficult for drugmakers to find commercial success in a conventional regulatory environment.
“Luckily for Big Pharma,” Jones wrote, the WHO and its private backers “are pursuing an unprecedented legal process that would cement loopholes that could solve these significant market challenges of at least some biotechnologies.”
Such loopholes made Pfizer and Moderna’s COVID-19 mRNA vaccines — the paradigmatic example of this new strategy — Big Pharma’s highest-selling annual market success ever.
Distribution of the COVID-19 vaccines to approximately 70% of people globally was possible only because of the “fast-tracked, deregulated development and mandated consumption of the experimental drugs,” Jones wrote.
The industry hopes to replicate that model with other drugs. And it has already begun — last month the Biomedical Advanced Research and Development Authority, or BARDA, gave Moderna $176 million to develop an mRNA bird flu vaccine.
Stakeholders behind the WHO have turned it into an arm of Big Pharma
According to Jones, the process of rapidly developed and mandated experimental drugs was first adopted by the U.S. military for bioweapons threats. Now, it is being internationally legitimized by the WHO through the agency’s revisions to the International Health Regulations (IHR) and its continued attempt to push its pandemic treaty.
The amendments were watered down and the treaty was partially thwarted at the last meeting of the World Health Assembly, which ended on June 1. However, the powers added to the amendments and the language in the treaty WHO and its backers are still hoping to advance next year show the type of biotech pandemic market Big Pharma has in the works.
According to Jones, this market:
“Will not be one that depends on the free will of consumers to opt in and out of products — but instead relies on tactics of forced consumption and manipulation of regulatory paradigms.
“At the forefront of this push are the WHO’s public-private-partners/private stakeholders, who directly shape and benefit from this policy. Their influence has, in effect, turned the WHO into an arm of Big Pharma, one so powerful that it already demonstrated its ability to morph the entire international regulatory process for the benefit of the pharmaceutical industry during the COVID-19 pandemic.”
These stakeholders can wield this power in part because the WHO receives 80% of its funding from private stakeholders.
Those stakeholders include private-sector giants like Bill Gates, his public-private partnership organizations like the Coalition for Epidemic Preparedness Innovations (CEPI) and public-sector bureaucrats, such as Dr. Anthony Fauci and Rick Bright, Ph.D., of BARDA and the Rockefeller Foundation, who have been working for years to create a new system that would speed up vaccine production.
During the COVID-19 pandemic period, even states that lacked legal structures to provide emergency authorization for new drugs created them, using the WHO’s Emergency Use Listing Procedure (EUL) as justification, and aided by the WHO’s COVAX vaccine distribution system. COVAX was co-led by the WHO, Gavi, CEPI and Unicef, which are all backed by Gates.
The goal now, Jones wrote, is to institutionalize the procedures that were put in place globally for COVID-19 to pave the way for a new pandemic market.
The One Health agenda, which requires “full-scale surveillance of the human-animal environment,” both before and during pandemics, is central to this plan, he wrote.
Did DOJ Lawyers Commit Fraud in the Omnibus Autism Proceeding?LEARN MORE
The four pillars of the emerging pandemic market
There are four pillars to the plan for securing this market. The pillars are embodied in the WHO’s recently passed IHR amendments and the proposed pandemic treaty.
1. Biosurveillance of “pathogens with pandemic potential”: The WHO is calling on member states to create infrastructure to conduct biosurveillance on entire populations.
WHO private stakeholders, like the Wellcome Trust and the Bill & Melinda Gates Foundation, have been funding such initiatives for years and continue to be at the forefront of similar initiatives today, Jones wrote.
2. Rapid sharing of data and research: Under the IHR amendments, the WHO’s director-general must provide support for member states’ research and development. In the pending treaty, that would include helping them rapidly share data during a pandemic.
Such sharing should help coordinate global pandemic responses and also “pandemic prevention.” That means building a globally coordinated effort to research and share data on diseases that don’t currently pose a public health threat but are allegedly “likely to cause epidemics in the future.”
The WHO’s announcement last week that it is facilitating data-sharing for a new mRNA bird flu vaccine from Argentina is one example.
Experts have raised concerns that incentivizing such “preventive R&D” could incentivize risky gain-of-function research, Jones wrote.
Jones also noted that it is “highly likely” that the same global organizations that partner with the WHO and are funded by its largest private donors will be the ones doing this research and development on vaccines for “future pathogens with pandemic potential” — and also the ones profiting from it.
3. New regulatory pathways: The WHO is developing new regulatory pathways for unapproved medical products to get to market during pandemic emergencies. The IHR amendments are vague on this, Jones wrote, but the proposed language of the treaty aims to speed up emergency authorizations of WHO-recommended investigational “relevant health products.”
The proposed treaty also seeks to compel member countries to take steps to ensure they have the “legal, administrative and financial frameworks in place to support emergency regulatory authorizations for the effective and timely approval of pandemic-related health products during a pandemic.”
4. Global mandates of unapproved products: The final key element in the Big Pharma-WHO plan to pave the way for a new pandemic market is shoring up the global capacity to mandate unapproved medical products.
According to Jones, in July 2023, the WHO adopted the European Union’s (EU) digital COVID-19 passport system, or the “immunity pass” which recorded people’s vaccination records, negative test results or records of previous infections.
“While a digital vaccine passport does not function as a hard mandate in which every citizen of a given population is forced to take a vaccine, it acts as a conditional mandate — one which offers the illusion of choice, but — in reality — restricts the civil liberties of those who do not comply,” Jones wrote.
The 2005 version of the IHR allowed for travel-based mandates that required proof of vaccination to enter countries when there was a public health risk. The new IHR, Jones wrote, expands on this by detailing the kinds of technology that can be used to check such information during future pandemics.
The WHO also is developing its Global Digital Health Certification Network, which expands the EU digital passport system to a global scale. It will digitize vaccination records and health records and will be “interoperable” with existing networks.
While interoperability makes it possible for decentralized data to be shared globally, Jones wrote, “The UN is seeking to impose digital identification as a ‘human right,’ or rather as a condition for accessing other human rights, for the entire global citizenry by 2030, as established in its Sustainable Development Goal 16.9.”
The initiative seeks to provide people with a “trusted, verifiable way” to prove who they are in the physical world and online.
“Verification systems of this size will place the right of citizens to do basic activities — like traveling, eating at a restaurant or working their job — in the hands of governments and potentially employers.
“The rights of civilians will be conditional, dictated by data stored in a massive digital hub that is global in its sharing abilities. Not only will domestic governments have access to the health information of their own citizens under this system, but an entire global bureaucracy will as well.”
EXCLUSIVE: Stock Market Expert Edward Dowd Predicts Multiple Black Swans Ahead of Presidential Election
Edward Dowd joined Alex Jones on the Tuesday show to give his expert analysis of the ongoing stock market crash.
Don’t miss:
Iran Gets Vaunted Missile Systems from Russia
Russia will provide Iran with Iskander missile systems and Murmansk-BN electronic warfare systems, the Kyiv Post reported recently, citing Israeli sources.
The first shipments have already arrived in Iran, along with the Russian specialists needed to operate them.
The Iskander is a missile system with a range of about 500 kilometers, while the Murmansk-BN can cripple electronic communication systems from a distance of up to 5,000 kilometers.
The Iskander is not particularly dangerous for Israel, which is more than 1,000 kilometers from Iran. However, it is possible to equip the system with R-500 cruise missiles, which have a range of up to 1,500 kilometers.
Recently, Sergei Shoigu, the chairman of the Russian National Security Council, visited Iran in person. Tensions in the region are now very high, and Iran could attack Israel at any time in retaliation for the suspected assassination of Ismail Haniyeh, the political leader of Hamas, it has been reported.
Russian President Vladimir Putin has previously warned as a theoretical possibility that Russia could equip countries hostile to America with advanced, long-range weapons.
EXCLUSIVE: Bilderberg Expert Daniel Estulin Exposes What’s Really Happening in War Between Israel and Iran
Geopolitical researcher and expert of the New World Order Daniel Estulin joined Alex Jones on his Tuesday show to discuss the current state of Middle East conflict.
Don’t miss:
Ransomware Attack on Blood Bank Forces Hundreds of Hospitals in Southeastern US to Activate Blood Shortage Protocols
OneBlood, a prominent non-profit blood donation center in Florida that serves hundreds of hospitals in the southeastern United States, has been targeted by a ransomware attack. Despite the attack, the organization continues to collect, test and distribute blood but at a “significantly reduced capacity.”
To address the disruptions, the blood bank adopted “manual processes and procedures to remain operational. However, these manual methods “take significantly longer to perform and impact inventory availability,” as explained by Susan Forbes, OneBlood’s senior vice president of Corporate Communications and Public Relations.
In an effort to manage the blood supply, the more than 250 hospitals served by OneBlood were forced to activate their critical blood shortage protocols.
OneBlood is figuring out the full extent of the cyber attack and what effect it has had on the organization’s data centers. As of press time, it is still not certain if customers’ personal information – such as test results, medical histories and blood types – have been compromised.
The attack on OneBlood is just the latest in a series of data breaches affecting the health care sector. Recently, a data breach of Kaiser Permanente is estimated to have affected roughly 13.4 million individuals, and a June report by data security firm SecurityScorecard warned that 34 percent of third-party data breaches in the U.S. in 2023 targeted health care organizations, far “outpacing every other sector.”
Ransomware attack could affect health of thousands of patients in the United States
OneBlood provides safe, available and affordable whole blood, platelets and other blood products to hundreds of hospitals across Alabama, Florida, North Carolina, South Carolina and Virginia. The loss of OneBlood’s services could affect the health of thousands of patients across the Southeastern United States.
“The blood supply cannot be taken for granted,” said Forbes. “The situation we are dealing with is ongoing. If you are eligible to donate, we urge you to please make an appointment to donate as soon as possible.”
The situation has become increasingly precarious for OneBlood amid the onset of Hurricane Debby, at a time when OneBlood needs to expedite its processes.
“Manual processes take longer to perform,” said Forbes. “We felt the impact of this the most when it came to labeling blood for release to hospitals.”
“Blood drives are taking place, our donor centers have remained open, and we continue to see a tremendous response from OneBlood donors answering the call for blood donations,” said Forbes.
The organization added that there is an urgent need for O positive, O negative and platelet donations. OneBlood has received significant aid from other blood centers across the country led by the Association for the Advancement of Blood and Biotherapies Task Force, which was formed to protect blood collection efforts in the event of natural disasters or acts of terrorism.
To aid in blood collection efforts, OneBlood’s 81 blood donation centers in 30 Florida counties are open to accept walk-ins, and the organization’s more than 250 “Big Red Buses” have been deployed across the state. These buses can often be seen at grocery store and shopping center parking lots, offering coupons, T-shirts and other merchandise to people willing to donate blood and platelets.
Visit Glitch.news for more similar stories.
Watch this video about OneBlood getting hit by ransomware attack, impacting its software systems.